1. Brown JM. Exploitation of bioreductive agents with vasoactive drugs. In: Proceedings of the 8th International Congress of Radiation Research, Edinburgh. Fielden EM, Fowler JF, Hendry JH; et al., editors. New York: Taylor and Francis; 1987. p. 719–724.
2. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo;Horsman;Int J Hyperthermia,1989
3. Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine;Siemann;Br J Cancer,1990
4. Chemical modification of tumour blood flow;Jirtle;Int J Hyper,1988
5. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSaII tumors;Kalmus;Cancer Res,1990